Fatty Liver (Nafld)
Non-Alcoholic Fatty Liver Disease (NAFLD)
Non-Alcoholic Fatty Liver Disease (NAFLD) is a significant health concern globally, characterized by the accumulation of fat in the liver cells of individuals who consume little to no alcohol. This condition has become increasingly prevalent in parallel with the rise in obesity and metabolic syndrome.
NAFLD encompasses a spectrum of liver conditions, ranging from simple steatosis (fatty liver) to non-alcoholic steatohepatitis (NASH), which involves inflammation and liver cell damage. If left untreated, NASH can progress to advanced liver fibrosis, cirrhosis, and even liver failure.
Several factors contribute to the development of NAFLD, including insulin resistance, obesity, genetics, and lifestyle factors such as a sedentary lifestyle and poor dietary habits. However, insulin resistance plays a central role, leading to increased fat accumulation in the liver.
Diagnosis of NAFLD typically involves a combination of medical history, physical examination, blood tests, imaging studies (such as ultrasound or MRI), and sometimes liver biopsy. Early detection and intervention are crucial to prevent disease progression and reduce the risk of complications.
Management of NAFLD focuses on lifestyle modifications, including weight loss, dietary changes (such as reducing sugar and saturated fat intake), regular exercise, and avoiding alcohol consumption. Pharmacological treatments may also be prescribed in some cases, although their efficacy is still under investigation.